Market Overview

CFTC Commissioner Bart Chilton Talks Benefits Of New Global Swaps Regulations

CFTC Commissioner Bart Chilton Talks Benefits Of New Global Swaps Regulations

The Commodities Futures Trading Commission's Bart Chilton pushed to pass new regulations on swaps trades on a global scale on CNBC's Squawk Box Friday morning. Today, the regulations passed 3-1.

Related: Sen. Elizabeth Warren (D-MA) Defends 21st Century Glass-Steagall Act

"We are doing a cross-border guidance for swaps trading. So, you know, risk knows no bound as we recall from 2008. But what we're doing specifically is we are phasing in our effective dates," Said Chilton.

According to Chilton, this regulation is more "cognizant" of what's happening globally.

"I look at global regulation sort of like Field of Dreams," said Chilton.

"Remember where the voice from the corn says 'If you build it, he will come' -- if we in the EU build global mark regulation, I think the rest of the world will come. That's good for markets, it's good for economy, and I think it's good for consumers ultimately."

The regulation, part of the Dodd-Frank Act, is aimed at "a global network of fairly harmonized rules and regulations," Chilton said.

In total, the new rules will take a total of seven months to phase in.

Posted-In: News Politics Topics Events Global Econ #s Economics Hot Best of Benzinga


Related Articles

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Mid-Afternoon Market Update: The Medicines Company Falls as Markets Remain Mixed

These ETFs Are Full of Recent Dividend Raisers